PMC:7105881 / 48768-48992 JSONTXT

{"project":"LitCovid-PubTator","denotations":[{"id":"1555","span":{"begin":22,"end":30},"obj":"Species"},{"id":"1556","span":{"begin":161,"end":165},"obj":"Species"},{"id":"1557","span":{"begin":177,"end":182},"obj":"Species"},{"id":"1563","span":{"begin":10,"end":21},"obj":"Species"}],"attributes":[{"id":"A1555","pred":"tao:has_database_id","subj":"1555","obj":"Tax:1335626"},{"id":"A1556","pred":"tao:has_database_id","subj":"1556","obj":"Tax:10090"},{"id":"A1557","pred":"tao:has_database_id","subj":"1557","obj":"Tax:9606"},{"id":"A1563","pred":"tao:has_database_id","subj":"1563","obj":"Tax:575864"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"Indeed, a recombinant MERS-CoV RBD (rRBD) fragment (residues 367–606) elicits RBD-specific antibody and cellular immune responses and neutralizing antibodies in mice and/or non-human primates (NHPs) (Lan et al., 2014, 2015)."}

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T284","span":{"begin":91,"end":99},"obj":"Body_part"}],"attributes":[{"id":"A284","pred":"fma_id","subj":"T284","obj":"http://purl.org/sig/ont/fma/fma62871"}],"text":"Indeed, a recombinant MERS-CoV RBD (rRBD) fragment (residues 367–606) elicits RBD-specific antibody and cellular immune responses and neutralizing antibodies in mice and/or non-human primates (NHPs) (Lan et al., 2014, 2015)."}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T604","span":{"begin":8,"end":9},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T605","span":{"begin":177,"end":182},"obj":"http://purl.obolibrary.org/obo/NCBITaxon_9606"},{"id":"T606","span":{"begin":183,"end":191},"obj":"http://purl.obolibrary.org/obo/NCBITaxon_9443"}],"text":"Indeed, a recombinant MERS-CoV RBD (rRBD) fragment (residues 367–606) elicits RBD-specific antibody and cellular immune responses and neutralizing antibodies in mice and/or non-human primates (NHPs) (Lan et al., 2014, 2015)."}

{"project":"LitCovid-PD-GO-BP","denotations":[{"id":"T99","span":{"begin":104,"end":129},"obj":"http://purl.obolibrary.org/obo/GO_0002456"},{"id":"T100","span":{"begin":104,"end":129},"obj":"http://purl.obolibrary.org/obo/GO_0002449"},{"id":"T101","span":{"begin":104,"end":129},"obj":"http://purl.obolibrary.org/obo/GO_0002443"}],"text":"Indeed, a recombinant MERS-CoV RBD (rRBD) fragment (residues 367–606) elicits RBD-specific antibody and cellular immune responses and neutralizing antibodies in mice and/or non-human primates (NHPs) (Lan et al., 2014, 2015)."}

{"project":"2_test","denotations":[{"id":"32265848-25405618-36511205","span":{"begin":212,"end":216},"obj":"25405618"},{"id":"32265848-26629538-36511206","span":{"begin":218,"end":222},"obj":"26629538"}],"text":"Indeed, a recombinant MERS-CoV RBD (rRBD) fragment (residues 367–606) elicits RBD-specific antibody and cellular immune responses and neutralizing antibodies in mice and/or non-human primates (NHPs) (Lan et al., 2014, 2015)."}

{"project":"LitCovid-sentences","denotations":[{"id":"T272","span":{"begin":0,"end":224},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Indeed, a recombinant MERS-CoV RBD (rRBD) fragment (residues 367–606) elicits RBD-specific antibody and cellular immune responses and neutralizing antibodies in mice and/or non-human primates (NHPs) (Lan et al., 2014, 2015)."}

{"project":"LitCovid-PMC-OGER-BB","denotations":[{"id":"T771","span":{"begin":22,"end":30},"obj":"SP_9"},{"id":"T772","span":{"begin":91,"end":99},"obj":"GO:0042571"},{"id":"T773","span":{"begin":104,"end":112},"obj":"GO:0051716"},{"id":"T774","span":{"begin":113,"end":119},"obj":"UBERON:0002405"},{"id":"T775","span":{"begin":147,"end":157},"obj":"GO:0042571"},{"id":"T776","span":{"begin":161,"end":165},"obj":"NCBITaxon:10088"},{"id":"T777","span":{"begin":177,"end":182},"obj":"SP_6;NCBITaxon:9606"},{"id":"T778","span":{"begin":183,"end":191},"obj":"NCBITaxon:9443"},{"id":"T56910","span":{"begin":22,"end":30},"obj":"SP_9"},{"id":"T50064","span":{"begin":91,"end":99},"obj":"GO:0042571"},{"id":"T86187","span":{"begin":104,"end":112},"obj":"GO:0051716"},{"id":"T62333","span":{"begin":113,"end":119},"obj":"UBERON:0002405"},{"id":"T49238","span":{"begin":147,"end":157},"obj":"GO:0042571"},{"id":"T20438","span":{"begin":161,"end":165},"obj":"NCBITaxon:10088"},{"id":"T72327","span":{"begin":177,"end":182},"obj":"SP_6;NCBITaxon:9606"},{"id":"T47058","span":{"begin":183,"end":191},"obj":"NCBITaxon:9443"}],"text":"Indeed, a recombinant MERS-CoV RBD (rRBD) fragment (residues 367–606) elicits RBD-specific antibody and cellular immune responses and neutralizing antibodies in mice and/or non-human primates (NHPs) (Lan et al., 2014, 2015)."}